» Articles » PMID: 37389129

M2 Macrophage-derived Extracellular Vesicles Augment Immune Evasion and Development of Colorectal Cancer Via a CircRNA_CCDC66/microRNA-342-3p/metadherin Axis

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 2023 Jun 30
PMID 37389129
Authors
Affiliations
Soon will be listed here.
Abstract

The M2 macrophages are major components in the tumor microenvironment and are closely linked to immune suppression and tumor metastasis. This work focuses on how M2 macrophage-derived extracellular vesicles (EVs) affect colorectal cancer (CRC) progression. THP-1 monocytes were induced to differentiate to M0 or M2 macrophages, and the macrophage-derived EVs (M0-EVs and M2-EVs, respectively) were collected and identified. The M2-EVs stimulation augmented proliferation, mobility, and the in vivo tumorigenic activity of CRC cells. Circular RNA_CCDC66 (circ_CCDC66) was highly enriched in M2-EVs and could be delivered into CRC cells. The RNA pull-down and luciferase assays showed that circ_CCDC66 could competitively bind to microRNA (miR)-342-3p, therefore restoring the expression of metadherin (MTDH) mRNA, a target transcript of miR-342-3p. Suppression of circ_CCDC66 in the M2-EVs or specific knockdown of MTDH in CRC significantly blocked the growth and mobility of CRC cells. However, miR-342-3p inhibition restored the malignant phenotype of cancer cells. Moreover, the MTDH knockdown was found to increase the cytotoxicity of CD8 T and reduce the protein level of the immune checkpoint PDL1 in CRC cells. In summary, this study reveals that the M2-EVs augment immune evasion and development of CRC by delivering circ_CCDC66 and restoring the MTDH level.

Citing Articles

Role of Triple-Negative Breast Cancer-Derived Extracellular Vesicles in Metastasis: Implications for Therapeutics and Biomarker Development.

Wan X, Yang L, Wu L, Lei J, Li J J Cell Mol Med. 2025; 29(5):e70448.

PMID: 40032646 PMC: 11875785. DOI: 10.1111/jcmm.70448.


Role of circular RNAs in cancer therapy resistance.

Liu W, Niu J, Huo Y, Zhang L, Han L, Zhang N Mol Cancer. 2025; 24(1):55.

PMID: 39994791 PMC: 11854110. DOI: 10.1186/s12943-025-02254-5.


Macrophage-derived extracellular vesicles as new players in chronic non-communicable diseases.

Lin F, Luo H, Wang J, Li Q, Zha L Front Immunol. 2025; 15:1479330.

PMID: 39896803 PMC: 11782043. DOI: 10.3389/fimmu.2024.1479330.


Circular RNAs: key players in tumor immune evasion.

Sanati M, Ghafouri-Fard S Mol Cell Biochem. 2025; .

PMID: 39754640 DOI: 10.1007/s11010-024-05186-8.


MiR-148a-3p Promotes Colorectal Cancer Cell Ferroptosis by Targeting SLC7A11.

Martino E, Balestrieri A, Aragona F, Bifulco G, Mele L, Campanile G Cancers (Basel). 2023; 15(17).

PMID: 37686618 PMC: 10486764. DOI: 10.3390/cancers15174342.

References
1.
Cao Y, Tu Y, Xiong J, Tan S, Luo L, Wu A . microRNA-15b-5p encapsulated by M2 macrophage-derived extracellular vesicles promotes gastric cancer metastasis by targeting BRMS1 and suppressing DAPK1 transcription. J Exp Clin Cancer Res. 2022; 41(1):152. PMC: 9027839. DOI: 10.1186/s13046-022-02356-8. View

2.
Smillie C, Sirey T, Ponting C . Complexities of post-transcriptional regulation and the modeling of ceRNA crosstalk. Crit Rev Biochem Mol Biol. 2018; 53(3):231-245. PMC: 5935048. DOI: 10.1080/10409238.2018.1447542. View

3.
Ganesh K, Stadler Z, Cercek A, Mendelsohn R, Shia J, Segal N . Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol. 2019; 16(6):361-375. PMC: 7295073. DOI: 10.1038/s41575-019-0126-x. View

4.
Hsiao K, Lin Y, Gupta S, Chang N, Yen L, Sun H . Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis. Cancer Res. 2017; 77(9):2339-2350. PMC: 5910173. DOI: 10.1158/0008-5472.CAN-16-1883. View

5.
Kong X, Duan Y, Sang Y, Li Y, Zhang H, Liang Y . LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2018; 234(6):9105-9117. DOI: 10.1002/jcp.27587. View